INTELLIGENT BIO SOLUTIONS INC. Diluted Shares Outstanding (Weighted Average)
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Diluted Shares Outstanding (Weighted Average) of 1.47 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.50M shares, a 257.34% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.59M shares, a 176.25% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 950.83K shares, a 109.63% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 8.55M shares, a 124.26% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for fiscal 2026 was 1.47M shares, a 179.27% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 527.36K shares, a 66.89% decline from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.59M shares, a 1802.54% increase from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 83.72K shares, a 88.58% decline from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | 2.05M shares derived: average of 2 quarters · filed 2026-08-19 | 1.68M shares derived: average of 3 quarters · filed 2026-08-19 | 1.47M shares 10-K · filed 2026-08-19 | ||||
| 2026-03-31 | 1.59M shares 10-Q · filed 2026-05-13 | 1.27M shares derived: average of 2 quarters · filed 2026-05-13 | 1.13M shares 10-Q · filed 2026-05-13 | 2.95M shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | 950.83K shares 10-Q · filed 2026-02-12 | 902.76K shares 10-Q · filed 2026-02-12 | 3.40M shares derived: average of 3 quarters · filed 2026-08-19 | 2.69M shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2025-09-30 | 8.55M shares 10-Q · filed 2025-11-12 | 4.62M shares derived: average of 2 quarters · filed 2026-08-19 | 3.27M shares derived: average of 3 quarters · filed 2026-08-19 | 2.57M shares derived: average of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | 699.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | 638.55K shares derived: average of 2 quarters · filed 2026-08-19 | 576.89K shares derived: average of 3 quarters · filed 2026-08-19 | 527.36K shares 10-K · filed 2026-08-19 | 5.27M shares 10-K · filed 2025-08-15 | |||
| 2025-03-31 | 577.19K shares 10-Q · filed 2026-05-13 | 5.77M shares 10-Q · filed 2025-05-13 | 515.39K shares derived: average of 2 quarters · filed 2026-05-13 | 469.85K shares 10-Q · filed 2026-05-13 | 4.70M shares 10-Q · filed 2025-05-13 | 1.97M shares derived: average of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | 453.58K shares 10-Q · filed 2026-02-12 | 4.54M shares 10-Q · filed 2025-02-13 | 417.35K shares 10-Q · filed 2026-02-12 | 4.17M shares 10-Q · filed 2025-02-13 | 2.44M shares derived: average of 3 quarters · filed 2026-02-12 | 2.35M shares derived: average of 4 quarters · filed 2026-02-12 | ||
| 2024-09-30 | 3.81M shares 10-Q · filed 2025-11-12 | 3.43M shares derived: average of 2 quarters · filed 2025-11-12 | 2.98M shares derived: average of 3 quarters · filed 2025-11-12 | 2.47M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 3.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | 2.56M shares derived: average of 2 quarters · filed 2025-08-15 | 2.02M shares derived: average of 3 quarters · filed 2025-08-15 | 1.59M shares 10-K · filed 2025-08-15 | ||||
| 2024-03-31 | 2.08M shares 10-Q · filed 2025-05-13 | 1.51M shares derived: average of 2 quarters · filed 2025-05-13 | 1.11M shares 10-Q · filed 2025-05-13 | 832.18K shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 949.66K shares 10-Q · filed 2025-02-13 | 571.93K shares 10-Q · filed 2025-02-13 | 416.28K shares derived: average of 3 quarters · filed 2025-02-13 | 335.31K shares derived: average of 4 quarters · filed 2025-02-13 | ||||
| 2023-09-30 | 194.20K shares 10-Q · filed 2024-11-07 | 2.33M shares 10-Q · filed 2023-11-08 | 149.59K shares derived: average of 2 quarters · filed 2024-11-07 | 130.52K shares derived: average of 3 quarters · filed 2024-11-07 | 116.81K shares derived: average of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | 104.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | 98.69K shares derived: average of 2 quarters · filed 2024-09-18 | 91.02K shares derived: average of 3 quarters · filed 2024-09-18 | 83.72K shares 10-K · filed 2024-09-18 | 1.00M shares 10-K · filed 2023-08-23 | |||
| 2023-03-31 | 92.39K shares 10-Q · filed 2024-05-08 | 84.04K shares derived: average of 2 quarters · filed 2024-05-08 | 76.63K shares 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | 75.69K shares 10-Q · filed 2024-02-09 | 68.87K shares 10-Q · filed 2024-02-09 | ||||||
| 2022-09-30 | 744.50K shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 733.26K shares 10-K · filed 2023-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |